Strong results for Prostatype® in yet another Asian study
In a recently completed study at Chang Gung Memorial Hospital in Taipei (Taiwan), Prostatype® once again demonstrates superiority in assessing the aggressiveness of individual patients' prostate cancer, this time in Taiwan, which has the one of the most advanced healthcare systems in the world. The study has been presented at the South East Asian Urology Association conference in Dubai by Professor Jacob Pang, leader of the study.In several previous studies, Prostatype® has demonstrated superiority in assessing the risk of an individual patient dying from prostate cancer or not, which is